01548.HK
Genscript Biotech Corporation
HKSE · Healthcare · Biotechnology · CN
HKD 39.34
+5.70%Margins
Gross margin
52.0%
EBITDA margin
23.5%
EBIT margin
14.9%
Net margin
-75.4%
FCF margin
28.6%
-16.4%
Return on equity
-13.3%
Return on assets
3.0%
Return on invested capital
0.18x
Asset turnover
HKD 2.6B
Cash from operations
HKD 2.97
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026